Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced Karen S. Lynch has been elected to its board of directors, effective February 19, 2025. The appointment ...

The planned closing of the pharmacy took some neighborhood leaders by surprise because the store often appeared busy, and it ...

CVS Health (CVS) has made an impressive comeback in 2025, with its stock soaring 45% so far this year. This sharp rebound ...

Korlym is Corcept's only approved drug, though the company (Nasdaq: CORT) asked the FDA in December to greenlight ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

In this article, we will look at the 10 Best Performing Healthcare Stocks So Far in 2025.

Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

The appointment marks the latest in a spate of leadership changes at CVS as the company’s insurance segment struggles to ...

CVS Health has named Ed DeVaney as president of CVS Caremark. Mr. DeVaney was appointed interim president of the pharmacy benefit manager in December, according to a Feb. 17 news release from CVS ...

DeVaney was named interim president of Caremark's PBM business in December 2024. CVS Health has named Ed DeVaney president of the company’s Caremark pharmacy benefit management business. Named interim ...

Earnings have fallen but are still strong enough to meet CVS Health's dividend commitment. Management expects adjusted ...